8:00 – 8:45 a.m.
The Mechanistic Basis of Cancer ImmunotherapyAbul Abbas, MD – University of California, San Francisco
8:45 – 9:30 a.m.
The Tumor MicroenvironmentScott Rodig, MD, PhD – Harvard Medical School
9:30 – 9:45 a.m.
Break
9:45 – 10:30 a.m.
CAR-T Cell Therapy: Principles and Current PracticesMarcela Maus, MD, PhD* – Harvard Medical School
10:30 – 11:15 a.m.
CAR-T Cell Therapy: Next Generation CARs Toxicities, Challenges and ProspectsMarcela Maus, MD, PhD* – Harvard Medical School
11:15 a.m. – Noon
Non-CAR Adoptive T Cell-Based TherapiesDaniel J. Powell Jr., PhD* – University of Pennsylvania
Noon – 12:45 p.m.
Lunch
12:45 – 1:30 p.m.
Checkpoint Blockade Therapy: Current Status, BiomarkersRyan Sullivan, MD* – Massachusetts General Hospital
1:30 – 2:00 p.m.
Next Generation Checkpoint and Combination TherapiesRyan Sullivan, MD* – Massachusetts General Hospital
2:00 – 3:00 p.m.
Antibody-cytokine Fusion ProteinsDario Neri, PhD – ETH Zürich
3:00 – 3:15 p.m.
3:15 – 4:00 p.m.
Immune-Related Toxicity: Mechanisms and ManagementKevan Herold, MD – Yale University
4:00 – 5:00 p.m.
Vaccination Strategies, Identification of NeoantigensGerald Linette, MD, PhD – The Hospital Of The University of Pennsylvania
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us